They require proper technique, clean supplies, and comfort with needles
Primary endpoints Energy expenditure and RER under indirect calorimetry, fat mass and adipocyte size, liver triglyceride content and histology, plasma lipids, and muscle performance form a coherent endpoint suite tied to ERR biology
Nausea occurred in approximately 24-33% of participants across all tirzepatide doses, but it was most common during dose escalation phases and typically resolved within two to three weeks of stabilizing at a new dose
Blood clots can stop the blood flowing to different body organs, leading ultimately to widespread organ damage resulting in devastating consequences, as strokes and possibly heart attacks
In general, peptide solutions remain stable for 3 or more weeks at +4C and 3-4 months at -20C